Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature

Figure 3

18F-FDG PET/CT performed 15 months after MTX withdrawal with an increased hypermetabolic activity in the spleen and a new hypermetabolic lesion involving the L4 vertebral body, consistent with progressive disease.